Dr. Vincent Giampapa, co-author of Younger Today, and his research team at Rutgers University have received a nomination for a 2014 Nobel Prize in the area of Stem Cell Research.
The Nobel Prize nomination was awarded for the potential impact Giampapa’s technology may have on the global aging epidemic, as well as the financial impact of future health care in all countries with aging demographics, especially in the United States.
After two years of research on the effects of young cells on old cells, Giampapa and Dr. Pranela Rameschwar have appeared to reverse the cellular aging process in humans as documented by changes in genes and proteins as well as cell function.
Originally presented by Giampapa in Rome at the Vatican Stem For Life meeting in April 2013 and then again in Stockholm at the Swedish American Life Science Summit, his research has documented the in-vitro approach can make cellular restoration possible.
Giampapa is an attending physician at Hackensack Medical Center, an Associate Clinical Professor at UMDNJ- Medical Center in New Jersey, and is also the founder of the Cell Health Institute. He has also received the EDISON Award this past year for innovation in the design of HealthyCell™, a new oral supplement based on natural plant extracts that helps keep cells healthier longer.
To learn how to implement Giampapa's findings in your own life and health, pick up a copy of Younger Today, which he co-authored with Carol Alt. You can read more about this breakthrough book at www.basichealthpub.com
No comments:
Post a Comment